NASDAQ
TNON
Last Price
US $0.20
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
Tenon Medical, Inc. cash flow to debt ratio of -7.62K% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial risk - Healthy cash flow growth.
Tenon Medical, Inc.'s free cash flow has decreased 9.48% from $-10.06M last year to $-11.02M, signaling decreasing performance
Financial risk - Healthy debt to equity ratio.
Tenon Medical, Inc.'s debt to equity ratio is 2.57, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy
Financial risk - Healthy debt to equity ratio development.
Tenon Medical, Inc.'s debt has increased relative to shareholder equity from 0.07 last year to 2.57 today, signaling weakened financials
Financial risk - Net debt/EBITDA.
Tenon Medical, Inc. has negative EBITDA, making leverage ratio unreliable
Financial stability - ICR.
Tenon Medical, Inc.'s interest coverage ratio of 70.62 indicates that earnings with good margin can cover interest payments on company debt
Financial stability - Profit margin growth.
Tenon Medical, Inc.'s profit margin has increased (-35.70%) in the last year from -417.24% to -268.28%, signaling increasing performance
Financial stability - Short term assets vs short term liabilities.
Tenon Medical, Inc.'s short-term assets of $6.77M exceed its short-term liabilities of $3.21M
Decreasing performance - ROA.
Tenon Medical, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
Tenon Medical, Inc.'s return on equity of -268.55%, is lower than 15.00%, indicating bad performance
Decreasing performance - Earnings quality.
Tenon Medical, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Decreasing performance - Earnings stability.
Tenon Medical, Inc. had positive net income in only 0.00 out of 5 years, indicating unstable earnings
Decreasing performance - Free cash flow.
Tenon Medical, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it
Decreasing performance - FCF yield.
Tenon Medical, Inc. has negative free cash flow, indicating cash burn
Increasing performance - Healthy earnings growth.
Tenon Medical, Inc.'s yearly earnings has increased -8.17% since last year from $-13.67M to $-12.56M, signaling increasing performance
Increasing performance - Healthy revenue growth.
Tenon Medical, Inc.'s yearly revenue has increased 20.35% since last year from $3.28M to $3.94M, signaling increasing performance
Decreasing performance - ROIC.
ROIC -136.22% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
Increasing performance - 3-year revenue CAGR.
Tenon Medical, Inc.'s 3-year revenue CAGR of 78.71% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
Tenon Medical, Inc. had revenue growth in 5.00 out of 5 years, indicating consistent revenue performance
Decreasing performance - ROE consistency.
Tenon Medical, Inc. had positive ROE in only 0.00 out of 5 years, indicating inconsistent returns on equity
Overvalued - DCF valuation.
Tenon Medical, Inc. has insufficient data to evaluate this check.
Overvalued - Earnings yield.
Tenon Medical, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - EBITDA valuation.
Tenon Medical, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
Overvalued - EV/EBITDA.
Tenon Medical, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable
Overvalued - PEG ratio value.
Tenon Medical, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Undervalued - P/B ratio.
Tenon Medical, Inc. has a price-to-book ratio of 1.22x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
Tenon Medical, Inc. has a price-to-sales ratio of 0.50x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
-268.55%
Return on equity
ROIC: -136.22%
Valuation History
-0.17X
Price to Earnings
EV/EBITDA: -0.17X
Cash flow
Profit margin
-46.29%
(FY vs FY)
Cash flow Y/Y
-56.72%
(FY vs FY)
Fair Value
Market $0.20
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.